Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV0Q | ISIN: CA87975M2085 | Ticker-Symbol: 3D0A
Frankfurt
01.04.25
08:03 Uhr
0,030 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TELO GENOMICS CORP Chart 1 Jahr
5-Tage-Chart
TELO GENOMICS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0670,08620:54
0,0000,00015:28

Aktuelle News zur TELO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
TELO GENOMICS Aktie jetzt für 0€ handeln
12.03.Telo Genomics Corp (2): Telo Genomics appoints Baechler as executive chairman4
12.03.Telo Genomics appoints Baechler executive chairman of the board of directors4
12.03.Telo Genomics Corp.: Telo Genomics Appoints Baechler Executive Chairman of The Board of Directors221Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...
► Artikel lesen
27.02.Telo Genomics Corp.: Telo Genomics Announces Expanded Partnership with Trusted Health Advisors377Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that, further to its engagement with Trusted Health...
► Artikel lesen
31.12.24Telo Genomics Corp (2): Telo Genomics 25,459,000-share private placement9
23.12.24Telo Genomics Corp (2): Telo Genomics closes $2.54-million private placement8
23.12.24Telo Genomics Corp.: Telo Genomics Closes Oversubscribed $2.5 Million Private Placement510Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce that, further to its news release...
► Artikel lesen
13.12.24Telo Genomics Corp (2): Telo Genomics arranges $2-million financing8
12.12.24Telo Genomics Corp.: Telo Genomics Announces Private Placement for up to $2 Million418Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce a non-brokered private placement...
► Artikel lesen
19.11.24Telo Genomics Corp (2): Telo Genomics receives approval from IPON program4
19.11.24Telo Genomics Corp.: Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)337Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
30.10.24Telo Genomics Corp (2): Telo Genomics amends May Clinic agreement12
30.10.24Telo Genomics Corp.: Telo Genomics Expands its Strategic Collaboration with Mayo Clinic315Toronto, Ontario--(Newsfile Corp. - October 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
22.10.24Telo Genomics Corp (2): Telo presents TeloViewSMM data at IMS 20243
22.10.24Telo Genomics Corp.: Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test308Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
10.09.24Telo Genomics Corp.: Telo Genomics Assessing MRD Status in TELO-DMRD Study550Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
13.08.24Telo Genomics Corp.: Telo Genomics Receives CLIA Certification467Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
18.06.24Telo Genomics Corp.: Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP431Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...
► Artikel lesen
12.06.24Telo Genomics Corp.: Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024400Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation...
► Artikel lesen
30.05.24Telo Genomics Corp.: Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology728Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), a biotech company developing the industry's leading telomere...
► Artikel lesen
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3